Publisher
Japanese Society on Thrombosis and Hemostasis
Reference10 articles.
1. 1) WOMAN Trial Collaborators: Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 389: 2105–2116, 2017.
2. 3) CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376: 23–32, 2010.
3. 9) Wanaka K, Okamoto S, Horie N, Hijikata-Okunomiya A, Okamoto U, Naito T, Ohno N, Bohgaki M, Tsuda Y, Okada Y: Use of an active center-directed plasmin inhibitor elucidates the multiplicity of plasmin actions. Thromb Res 82: 79–86, 1996.
4. 10) Okamoto S, Wanaka K, Hijikata-Okunomiya A, Okada Y, Katsuura Y: A finding of highly selective synthetic inhibitor of plasma kallikrein; its action to bradykinin generation, intrinsic coagulation and experimental DIC. Agents Actions (Suppl.) 38(pt1): 198–205, 1992.
5. 11) Okamoto S, Hijikata-Okunomiya A, Wanaka K, Okada Y, Okamoto U: Enzyme-controlling medicines: introduction. Semin Thromb Hemost 23: 493–501, 1997.